Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials
Diabetes, Obesity and Metabolism · 2026-10 · 28 (10) · 9701-9703
DOI: 10.1111/dom.71087 ↗At a glance
Leserbrief in Diabetes, Obesity and Metabolism, published online on 2026-07-06. Written by Mika Ukkonen and 5 co-authors. Institution: Department of Surgery, Wellbeing Services of County of Central Finland, Jyväskylä, Finland. Cited 1 times so far (Crossref); 8 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Topics: Patientensicherheit
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Department of Surgery, Wellbeing Services of County of Central Finland, Jyväskylä, Finland.
- School of Medicine, University of Eastern Finland, Kuopio, Finland.
- Department of Surgery, Kuopio University Hospital, Kuopio, Finland.
ORCID profiles: Mika Ukkonen
Cite
APA
Ukkonen, M., Kivivuori, A., Starckjohann, P., Lammi, P., Junttila, A., & Panula, V. (2026). Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials. Diabetes, Obesity and Metabolism, 28(10), 9701-9703. https://doi.org/10.1111/dom.71087
Vancouver
Ukkonen M, Kivivuori A, Starckjohann P, Lammi P, Junttila A, Panula V. Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials. Diabetes, Obesity and Metabolism. 2026;28(10):9701-9703. doi:10.1111/dom.71087
BibTeX
@article{Ukkonen2026,
author = {Ukkonen, Mika and Kivivuori, Antti and Starckjohann, Peter and Lammi, Pekka and Junttila, Anna and Panula, Valtteri},
title = {Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {10},
pages = {9701--9703},
doi = {10.1111/dom.71087}
}
EUVIMED